Bitcoin price today: falls to 2-week low below $113k ahead of Fed Jackson Hole
Huron Consulting Group Inc. (NASDAQ:HURN), whose stock has surged nearly 60% over the past year and is currently trading near its 52-week high of $153.77, saw Director H. Eugene Lockhart recently sell a significant portion of his holdings in the company. According to a recent SEC filing, Lockhart sold 12,500 shares of Huron’s common stock on February 26, 2025. The shares were sold at a price of $150 each, amounting to a total transaction value of $1,875,000. The transaction comes as InvestingPro data indicates the stock is trading in overbought territory, with a market capitalization of $2.49 billion.
Following this transaction, Lockhart retains ownership of 12,172 shares in the consulting firm. The sale was executed automatically under a Rule 10b5-1 trading plan, which had been adopted by Lockhart on May 9, 2024. Such plans allow insiders to set up a predetermined schedule for selling stocks to avoid potential conflicts of interest. For deeper insights into insider trading patterns and 13 additional key metrics, check out the comprehensive InvestingPro Research Report.
In other recent news, Huron Consulting Group reported record fourth-quarter 2024 financial results, with earnings per share (EPS) of $1.90, significantly surpassing the analyst estimate of $1.52. The company’s revenue for the quarter reached $399.31 million, exceeding the anticipated $379.99 million. For the full year 2024, Huron achieved record revenues of $1.49 billion, marking a 9.1% increase from the previous year, while net income rose by 86.7% to $116.6 million. Looking ahead, Huron has provided guidance for 2025, forecasting an EPS range of $6.80-$7.60 and revenue projections between $1.58-1.66 billion, aligning with consensus estimates.
In response to these strong results, both Benchmark and Truist Securities analysts have raised their price targets for Huron Consulting Group to $165 from the previous $140, maintaining a Buy rating. Analysts from these firms highlighted Huron’s potential in the healthcare sector, particularly due to regulatory changes and the company’s focus on margin expansion. Huron’s guidance also suggests conservative estimates with projected revenue and adjusted EBITDA growth surpassing consensus expectations. Additionally, Huron plans to host an Investor Day on March 25, 2025, to discuss its strategic and financial goals further.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.